Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, Cardiff, CF64 2XX, UK.
Health Economics and Outcomes Research Ltd, Cardiff, UK.
Adv Ther. 2022 Jan;39(1):33-43. doi: 10.1007/s12325-021-01927-z. Epub 2021 Nov 5.
Chronic kidney disease (CKD) is a complex disease which affects approximately 13% of the world's population. Over time, CKD can cause renal dysfunction and progression to end-stage kidney disease and cardiovascular disease. Complications associated with CKD may contribute to the acceleration of disease progression and the risk of cardiovascular-related morbidities. Early CKD is asymptomatic, and symptoms only present at later stages when complications of the disease arise, such as a decline in kidney function and the presence of other comorbidities associated with the disease. In advanced stages of the disease, when kidney function is significantly impaired, patients can only be treated with dialysis or a transplant. With limited treatment options available, an increasing prevalence of both the elderly population and comorbidities associated with the disease, the prevalence of CKD is set to rise. This review discusses the current challenges and the unmet patient need in CKD.
慢性肾脏病(CKD)是一种复杂的疾病,影响着全球约 13%的人口。随着时间的推移,CKD 可导致肾功能障碍,并进展为终末期肾病和心血管疾病。与 CKD 相关的并发症可能导致疾病的加速进展和心血管相关并发症的风险增加。早期 CKD 无症状,仅在疾病的并发症出现时,如肾功能下降和与疾病相关的其他合并症出现时才出现症状。在疾病的晚期,当肾功能严重受损时,患者只能接受透析或移植治疗。由于治疗选择有限,老年人口和与疾病相关的合并症的患病率不断增加,因此 CKD 的患病率呈上升趋势。本综述讨论了 CKD 目前面临的挑战和未满足的患者需求。